Brief ReportBrief Report
Cannabinoid Hyperemesis Syndrome in an Athlete
Brady Fleshman and Kim Kaiser
The Journal of the American Board of Family
Medicine July 2021, 34 (4) 811-813; DOI: https://doi.org/10.3122/jabfm.2021.04.200586
Brady Fleshman
From the Assistant Professor of Family and Community Medicine, Assistant Professor of Orthopaedics and Sports Medicine, University of Missouri, Columbia, MO (BF); Associate Professor of Family and Community Medicine, Associate Professor of Orthopaedics and Sports Medicine, University of Kentucky, Lexington, KY (KK).
MDKim Kaiser
From the Assistant Professor of Family and Community Medicine, Assistant Professor of Orthopaedics and Sports Medicine, University of Missouri, Columbia, MO (BF); Associate Professor of Family and Community Medicine, Associate Professor of Orthopaedics and Sports Medicine, University of Kentucky, Lexington, KY (KK).
MD
References
- 1.↵Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health (HHS Publication No. PEP19-5068, NSDUH Series H-54). Substance Abuse and Mental Health Services Administration. Available from: https://www.samhsa.gov/data/. Published 2019. Accessed March 15, 2020.
- 2.↵
- Cook M
- 3.↵
- Allen JH,
- de Moore GM,
- Heddle R,
- Twartz JC
- 4.↵
- 5.↵
- DeVuono MV,
- Parker LA
- 6.↵
- Iacopetti CL,
- Packer CD
- 7.↵
- Simonetto DA,
- Oxentenko AS,
- Herman ML,
- Szostek JH
- 8.↵
- Richards JR
- 9.↵
- 10.↵
- Patterson DA,
- Smith E,
- Monahan M,
- et al
In this issue
Cannabinoid Hyperemesis Syndrome in an Athlete
Brady Fleshman, Kim Kaiser
The Journal of the American Board of Family
Medicine Jul 2021, 34 (4) 811-813; DOI: 10.3122/jabfm.2021.04.200586
Jump to section
Related Articles
- No related articles found.